SALVATORI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 2.144
EU - Europa 1.014
AS - Asia 682
SA - Sud America 11
OC - Oceania 2
AF - Africa 1
Totale 3.854
Nazione #
US - Stati Uniti d'America 2.143
CN - Cina 407
IT - Italia 237
PL - Polonia 198
UA - Ucraina 168
DE - Germania 155
SG - Singapore 128
TR - Turchia 82
GB - Regno Unito 74
SE - Svezia 57
FI - Finlandia 42
FR - Francia 28
ID - Indonesia 24
IR - Iran 15
BE - Belgio 13
CZ - Repubblica Ceca 10
BR - Brasile 9
RU - Federazione Russa 9
RO - Romania 8
NL - Olanda 7
IN - India 5
MY - Malesia 4
VN - Vietnam 4
CH - Svizzera 3
ES - Italia 3
IQ - Iraq 3
TW - Taiwan 3
AU - Australia 2
KR - Corea 2
AR - Argentina 1
CA - Canada 1
CO - Colombia 1
GE - Georgia 1
IE - Irlanda 1
JP - Giappone 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
PK - Pakistan 1
TN - Tunisia 1
Totale 3.854
Città #
Woodbridge 290
Chandler 219
Jacksonville 204
Warsaw 198
Houston 162
Beijing 148
Ann Arbor 138
Fairfield 137
Ashburn 127
Wilmington 91
Singapore 90
Nanjing 69
Ferrara 64
Izmir 53
Bologna 52
Seattle 49
Princeton 46
Addison 41
New York 41
Cambridge 40
Shanghai 36
Boardman 33
Milan 33
Bremen 28
Jakarta 24
Shenyang 20
Los Angeles 19
Redwood City 18
Santa Clara 17
Auburn Hills 16
Falls Church 14
Hebei 14
San Diego 14
Dearborn 13
Nanchang 13
Brussels 12
Jiaxing 12
Munich 11
Brno 10
Changsha 10
Tianjin 10
San Jose 9
Mountain View 8
Guangzhou 7
Leiden 7
Hefei 6
Jinan 6
Lanzhou 6
Ningbo 6
Zhengzhou 6
Cattolica 5
Des Moines 5
Cagliari 4
Dong Ket 4
Fuzhou 4
Helsinki 4
Indiana 4
Kunming 4
Leawood 4
Napoli 4
Norwalk 4
Orange 4
Padova 4
Ravenna 4
Alcamo 3
Hangzhou 3
Kundan 3
Pars 3
Taipei 3
Turin 3
Ankara 2
Ardabil 2
Ashwell 2
Besana in Brianza 2
Campobasso 2
Castello Di Fiemme 2
Chengdu 2
Custom House 2
Edinburgh 2
Kansas City 2
Kilburn 2
Kirkuk 2
Kota Bharu 2
Kuala Lumpur 2
London 2
Modena 2
Rome 2
San Mateo 2
Southwark 2
Sydney 2
Anna 1
Augusta 1
Barcelona 1
Beirut 1
Bogotá 1
Boston 1
Bovisio Masciago 1
Buenos Aires 1
Carini 1
Carnago 1
Totale 2.823
Nome #
Strategies for the adult haemoglobin (HbA) production in β0-thalassemia patients 171
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 167
SPR-based non-invasive prenatal testing for fetal sex determination 145
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 139
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 137
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 136
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 118
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 112
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 111
null 107
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 104
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients. 99
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 97
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 96
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 94
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 91
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 85
null 85
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 84
Gene therapy combined with HbF induction in beta-thalassemia 82
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 81
Development and molecular characterization of transgenic mice for beta-thalassemia 78
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 76
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 75
null 75
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 72
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 70
null 69
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 68
Gene therapy and fetal hemoglobin induction 67
PNA-mediated alteration of mRNA splicing 66
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 64
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 63
Cellular biosensors for the identification of fetal hemoglobin inducers 62
Generation and molecular characterization of a transgenic mouse line carrying a mutated human °39 thalassemia -globin gene 60
Readthrough of the premature stop codon beta039-thalassemia 59
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 58
Production of a cellular model for the screening of inducers of fetal haemoglobin 58
Control of Erwinia amylovora Growth by Moringa oleifera Leaf Extracts: In Vitro and in Planta Effects 56
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 51
UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation 43
Effects of Moringa oleifera Leaf Extracts on Xanthomonas campestris pv. campestris 42
null 40
PLCB3 Loss of Function Reduces Pseudomonas aeruginosa-Dependent IL-8 Release in Cystic Fibrosis 39
Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia 38
Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells 36
Evidences for miRNA regulation of BCL11A gene expression 25
LINE-1 global DNA methylation, iron homeostasis genes, sex and age in sudden sensorineural hearing loss (SSNHL) 20
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 20
Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance 15
Peptide nucleic acids targeting the murine beta-globin mRNAs selectively inhibit hemoglobin production in Murine Erythroleukemia (MEL) cells. 15
Tobramycin is a suppressor of premature termination codons. 12
circRNAs as Epigenetic Regulators of Integrity in Blood–Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis 9
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach 9
Totale 3.951
Categoria #
all - tutte 17.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 420
Totale 18.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020488 0 0 21 70 31 70 46 53 42 102 34 19
2020/2021614 53 41 24 42 47 58 22 56 25 66 124 56
2021/2022469 45 39 13 15 29 23 22 18 15 44 39 167
2022/2023496 57 53 11 63 94 63 28 40 41 9 21 16
2023/2024385 22 40 19 7 32 64 56 25 5 18 23 74
2024/2025194 56 34 104 0 0 0 0 0 0 0 0 0
Totale 3.951